Cardinal Health gets FDA approval for Lymphoseek
DUBLIN, Ohio — Cardinal Health announced on Thursday that Lymphoseek (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies (SLNB) – has been approved for pediatric use by the U.S. Food and Drug Administration (FDA). “This new indication opens the door
